Annual Working Capital
$148.34 M
-$25.92 M-14.87%
December 31, 2023
Summary
- As of February 7, 2025, AVBP annual working capital is $148.34 million, with the most recent change of -$25.92 million (-14.87%) on December 31, 2023.
- During the last 3 years, AVBP annual working capital has risen by +$107.21 million (+260.64%).
- AVBP annual working capital is now -14.87% below its all-time high of $174.26 million, reached on December 31, 2022.
Performance
AVBP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$148.34 M
-$148.07 M-49.95%
September 1, 2024
Summary
- As of February 7, 2025, AVBP quarterly working capital is $148.34 million, with the most recent change of -$148.07 million (-49.95%) on September 1, 2024.
- Over the past year, AVBP quarterly working capital has dropped by -$148.07 million (-49.95%).
- AVBP quarterly working capital is now -53.28% below its all-time high of $317.50 million, reached on March 31, 2024.
Performance
AVBP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AVBP Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.9% | -50.0% |
| 3 y3 years | +260.6% | -50.0% |
| 5 y5 years | +260.6% | -50.0% |
AVBP Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.9% | +260.6% | -53.3% | at low |
| 5 y | 5-year | -14.9% | +260.6% | -53.3% | at low |
| alltime | all time | -14.9% | +260.6% | -53.3% | at low |
ArriVent BioPharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $148.34 M(-50.0%) |
| Jun 2024 | - | $296.41 M(-6.6%) |
| Mar 2024 | - | $317.50 M(+114.0%) |
| Dec 2023 | $148.34 M | $148.34 M(-12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $169.88 M(-8.6%) |
| Jun 2023 | - | $185.87 M(+6.7%) |
| Dec 2022 | $174.26 M(+323.6%) | - |
| Dec 2022 | - | $174.26 M |
| Dec 2021 | $41.13 M | - |
FAQ
- What is ArriVent BioPharma annual working capital?
- What is the all time high annual working capital for ArriVent BioPharma?
- What is ArriVent BioPharma annual working capital year-on-year change?
- What is ArriVent BioPharma quarterly working capital?
- What is the all time high quarterly working capital for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly working capital year-on-year change?
What is ArriVent BioPharma annual working capital?
The current annual working capital of AVBP is $148.34 M
What is the all time high annual working capital for ArriVent BioPharma?
ArriVent BioPharma all-time high annual working capital is $174.26 M
What is ArriVent BioPharma annual working capital year-on-year change?
Over the past year, AVBP annual working capital has changed by -$25.92 M (-14.87%)
What is ArriVent BioPharma quarterly working capital?
The current quarterly working capital of AVBP is $148.34 M
What is the all time high quarterly working capital for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly working capital is $317.50 M
What is ArriVent BioPharma quarterly working capital year-on-year change?
Over the past year, AVBP quarterly working capital has changed by -$148.07 M (-49.95%)